Roche to release Tamiflu data to Cochrane

Roche (SIX:ROG; OTCQX:RHHBY) said it will provide clinical study reports (CSRs) for all Roche-sponsored trials of influenza drug Tamiflu oseltamivir to the Cochrane Collaboration -- a not-for-profit that publishes evidence-based healthcare reviews -- over the next few months. The pharma said it will first edit each CSR, which is about 2,000-3,000 pages, to "ensure patient confidentiality and to protect legitimate commercial interests." Cochrane first requested data from the 74 Roche-sponsored Tamiflu trials in 2009. ...